hrp0092rfc13.2 | Adrenals and HP Axis | ESPE2019
Bacila Irina-Alexandra
, Adaway Jo
, Hawley James
, Mahdi Sundus
, Acerini Carlo L
, Krone Ruth
, Patel Leena
, Alvi Sabah
, Randell Tabitha
, Gevers Evelien
, Dattani Mehul
, Cheetham Timothy
, Kyriakou Andreas
, Schiffer Lina
, Ryan Fiona
, Crowne Elizabeth
, Davies Justin H
, Ahmed S Faisal
, Keevil Brian
, Krone Nils P
Introduction: Glucocorticoid treatment remains a challenging aspect in the management of congenital adrenal hyperplasia (CAH). Current strategies for monitoring treatment are suboptimal and rely largely on frequent blood tests, which are traumatising in children and young persons (CYP). Recent evidence indicates a crucial role of 11-oxygenatedC19 androgens in the pathogenesis of CAH.Aim: To explore the use of 11-oxygenat...